IP Library Granted Patent US 12,280,181
Granted Patent B2
US 12,280,181 · App. 18/176,435 · Granted Apr 22, 2025

Intravascular devices

Inventors: Hancun Chen (San Ramon, CA); Andrew S. Lee (San Jose, CA); Brent Gerberding (San Jose, CA)
Assignees: Stryker Corporation; Stryker European Operations Limited
A61L31/022A61L31/14A61B17/1214A61F2002/016A61F2002/068A61F2/90A61F2/95C22C5/04C22C27/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,181
App. No.
18/176,435
Granted
Apr 22, 2025
Kind
B2
Abstract

An implantable medical device includes an elongate member having a cross-sectional dimension that is less than 0.00085 inch, wherein the elongate member is made from a material comprising a platinum-tungsten alloy having a percentage of tungsten that is at least 10% by weight or alternatively the implantable medical device includes an elongate member made from a material comprising an alloy containing rhenium.

Claims (30)

1. An implantable medical device, comprising:

an elongate member made from a material comprising an alloy containing rhenium in combination with zirconium and/or hafnium;

wherein the elongate member forms a part of a braid having a cross-section with a width W and a thickness T when the braid is unconfined outside a tube, wherein a ratio of W/T is equal to or greater than 2, wherein the braid is configured to roll up so that the cross-section of the braid has a collapsed width W′ when the braid is inside the tube, and wherein the collapsed width W′ of the cross-section when the braid is inside the tube is less than the width W of the cross-section when the braid is outside the tube.

2. The implantable medical device of claim 1 , wherein the elongate member has a cross-sectional dimension that is less than 0.00085 inch.

3. The implantable medical device of claim 1 , wherein the alloy comprises a molybdenum-rhenium alloy.

4. The implantable medical device of claim 1 , wherein the alloy comprises a tungsten-rhenium alloy.

5. The implantable medical device of claim 1 ,

wherein the implantable medical device has a longitudinal axis and a length measured in a direction of the longitudinal axis that is at least 1.2 inch,

wherein the implantable medical device is insertable lengthwise into an inner lumen of the tube having an inner lumen diameter not greater than 0.02 inch, and

wherein the implantable medical device has a column strength sufficient to allow the implantable medical device to be pushed through the lumen without undergoing buckling, kinking, or plastic deformation.

6. The implantable medical device of claim 1 , wherein the elongate member has a greater ultimate tensile strength, a greater Young's modulus, and a lesser magnetic susceptibility, respectively, than those of an identically dimensioned alternative elongate member composed of an alternative alloy that does not include Rhenium and has a percentage of tungsten that is no more than 8% by weight.

7. The implantable medical device of claim 1 , wherein the elongate member has a Young's modulus of 30 Msi or higher.

8. The implantable medical device of claim 1 , wherein the elongate member has an ultimate tensile strength (UTS) that is 350 ksi or higher.

9. The implantable medical device of claim 1 , wherein the material further comprises one or more of Ta, Ir, Rh, Ru, Mo, and Au.

10. The implantable medical device of claim 1 , wherein the alloy contains rhenium in combination with both zirconium and hafnium.

11. The implantable medical device of claim 1 , wherein the alloy contains rhenium in combination with zirconium or hafnium, but not both zirconium and hafnium.

12. An implantable medical device, comprising:

an elongate member having a cross-sectional dimension that is less than 0.00085 inch,

wherein the implantable medical device has a longitudinal axis and a length measured in a direction of the longitudinal axis that is at least 1.2 inch,

wherein the implantable medical device is insertable lengthwise into a tube having a lumen, at least a part of the lumen having a diameter not greater than 0.02 inch;

wherein the elongate member is made out of an alloy comprising rhenium in combination with zirconium and/or hafnium; and

wherein the elongate member forms a part of a braid having a cross-section with a width W and a thickness T when the braid is outside the tube, wherein a ratio of W/T is equal to or greater than 2, wherein the braid is configured to roll up so that the cross-section of the braid has a collapsed width W′ when the braid is inside the tube, and wherein the collapsed width W′ of the cross-section when the braid is inside the tube is less than the width W of the cross-section when the braid is outside the tube.

13. The implantable medical device of claim 12 , wherein the implantable medical device has a column strength sufficient to allow the implantable medical device to be pushed through the lumen of the tube without undergoing buckling, kinking, or plastic deformation.

14. The implantable medical device of claim 12 , wherein the alloy comprises a molybdenum-rhenium alloy.

15. The implantable medical device of claim 12 , wherein the alloy comprises a tungsten-rhenium alloy.

16. The implantable medical device of claim 12 , wherein the elongate member has a Young's modulus of 30 Msi or higher.

17. The implantable medical device of claim 12 , wherein the elongate member has an ultimate tensile strength (UTS) that is 350 ksi or higher.

18. The implantable medical device of claim 12 , wherein the material further comprises one or more of Ta, Ir, Rh, Ru, Mo, and Au.

19. The implantable medical device of claim 1 , wherein the braid is configured to roll up longitudinally around a longitudinal axis of the tube when the braid is inside the tube.

20. The implantable medical device of claim 12 , wherein the braid is configured to roll up longitudinally around a longitudinal axis of the tube when the braid is inside the tube.

Assignments (2)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: CHEN, HANCUN; LEE, ANDREW S.; GERBERDING, BRENT
To: STRYKER CORPORATION; STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 062847/0398 →